Koyfin Home > Directory > Health Care > LA Jolla Pharma > Long-Term Debt

LA Jolla Pharma Long-Term Debt Chart (LJPC)

LA Jolla Pharma annual/quarterly Long-Term Debt from 2018 to 2020.
  • LA Jolla Pharma Long-Term Debt for the quarter ending June 06, 2020 was $124m a 0.03% increase of 0m year over year
  • LA Jolla Pharma Long-Term Debt for the last 12 months ending June 06, 2020 was $124m a 0.03% increase of 0m year over year
  • LA Jolla Pharma Annual Long-Term Debt for 2019 was $124m a 0.05% increase of 0m from 2018
  • LA Jolla Pharma Annual Long-Term Debt for 2018 was $124m
Other Cash Flow Metrics:
  • LA Jolla Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-32m a -43.12% increase of 14m year over year
  • LA Jolla Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-50m a 42.74% decrease of -22m year over year
  • LA Jolla Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a 97.55% increase of 3m year over year
View Chart On Koyfin

Quarterly LJPC Long-Term Debt Data

06/2020$124m
03/2020$124m
12/2019$124m
09/2019$124m
06/2019$124m
03/2019$124m
12/2018$124m
09/2018$124m
06/2018$124m

Annual LJPC Long-Term Debt Data

2019$124m
2018$124m